Skip to Main Content

Paper Details

Reply to letter to the editor regarding "Efficacy and safety of finerenone in patients with chronic kidney disease: a systematic review with meta-analysis and trial sequential analysis".
Ann Palliat Med
0
2021
Author NameAffiliation
Chao LiuChinese PLA General Hospital, Chinese PLA Institute of Nephrology, National Clinical Research Center for Kidney Diseases
  • 1 - 1

Datasets

Release 1.2